Program Details
- Intended Audience: Pharmacists interested in ordering and dispensing HIV PEP
- Universal Activity Number: 0012-0000-25-005-H02-P
- Contact Hours: 2.0 Recertification General hours of ACPE continuing education for pharmacists.
- Program Fees:
- Regular Registration: $25.00
- UF Preceptor/Career Coach: $20.00
- UF COP Faculty: $15.00
- UAN Release Date: 02/14/2025
- UAN Expiration Date: 02/14/2028
- Activity Type: Knowledge
- Program Support: No outside financial support was provided.
- Format Type: This course is self-paced, fully online.
- Time to Complete: All coursework must be completed within 24 weeks from the date of registration or before date of UAN expiration,02/14/2028 , whichever comes first. This course will no longer be eligible for CE credit after 02/14/2028.
Summary
Pharmacists are often the most accessible healthcare providers, close to patients and embedded in their communities, with more than 90% of people in the U.S. living within five miles of a pharmacy. Because of this accessibility, pharmacists play a crucial role in controlling the HIV/AIDS epidemic, increasing timely access to HIV postexposure prophylaxis (PEP) to prevent infection.
This activity will build upon the HIV material covered within the Collaborative Practice Certification Program, introducing PEP guidelines for antiretroviral treatment following potential exposure to HIV. Upon completion of this activity, pharmacists providing services under a written collaborative practice agreement will have the clinical knowledge necessary to practice under an access-to-care plan, in which a collaborating physician authorizes the pharmacist to screen adults for HIV exposure or order and dispense HIV PEP under the written collaborative practice agreement.
This course is approved by the Florida Board of Pharmacy for 2.0 contact hours to meet requirements pursuant to CHAPTER 64B16-26, Florida Statutes, and Rule 64B16-26.300, Florida Administrative Code.
Objectives
At the completion of this activity, the participant will be able to:
- Perform patient assessments to determine if post-exposure prophylaxis is indicated.
- Perform point-of-care testing procedures.
- Provide safe and effective treatment of HIV exposure with HIV infection prevention drugs, including, but not limited to, consideration of the side effects of the drug dispensed and the patient’s diet and activity levels.
- Identify contraindications for HIV exposure treatment.
- Identify patient comorbidities in individuals with HIV requiring further medical evaluation and treatment, including, but not limited to, cardiovascular disease, lung and liver cancer, chronic obstructive lung disease, and diabetes mellitus
Program Overview
Lecture: HIV Post-Exposure Prophylaxis
Requirements for Successful Course Completion
In order to earn credit for this course, participants must pass a final assessment with a score of 70% or higher. Two chances to pass the assessment will be given. If a passing score is not earned by the second attempt, the participant must re-enroll in the course. Upon successful completion of all coursework, participants must complete a course evaluation form.
Course Access
To access your course after enrollment, please click the link below.
Click the blue “Log in to Continuing Education” button and enter your login credentials. You should then see your course on the Canvas dashboard or by clicking Courses>All Courses.
Disclosure Statement
The following speakers, reviewers, and planning committee members have disclosed that he/she has no relevant financial disclosures. No other speaker, reviewer, or planning committee member in a position to control content has any financial relationships to disclose.
Teresa E Roane PharmD, MBA, BCACP
Jennifer W Janelle M.D.
Eric F Egelund Ph.D., Pharm.D.
Additional Resources
Please review the resources below before registering for the course.
The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.